A company's marketing division launches an aggressive advertising campaign containing unsubstantiated and false performance claims about a medical device. What is the most severe risk this campaign poses to the organization?
Select an answer to reveal the explanation.
Short Explanation and Infographic
We've all seen those over-the-top ads promising the moon, but when a marketing team goes too far and starts making flat-out false claims, they are playing with fire. Trust me, the regulators—like the FTC or FDA—are watching, and so are class-action attorneys. If your ads lie about what your product can do, you're looking at a world of pain. We're talking massive fines, lawsuits from angry customers, and a public relations disaster that can destroy your brand overnight. The marketing team might be focused on hitting their quarterly sales numbers, but it's your job in compliance to make sure they don't drag the whole company into court. Keep those ads honest, because a bad ad is a fast track to regulatory misery.
Full explanation below image
Full Explanation
Misleading or false advertising represents a severe compliance risk that spans multiple legal and regulatory domains. Regulatory bodies, such as the Federal Trade Commission (FTC) in the United States and equivalent international authorities, strictly enforce truth-in-advertising standards. Option C is correct because the consequences of deceptive advertising are multi-faceted and highly damaging. First, the organization faces legal action from regulatory agencies, which can result in injunctions, corrective advertising mandates, and substantial civil penalties. Second, it exposes the company to private civil litigation, including class-action lawsuits filed by misled consumers seeking damages. Finally, the resulting negative publicity can cause long-term reputational damage, leading to a loss of customer trust and a decline in market share and valuation. Option A is incorrect because low audience engagement, while disappointing to the marketing department, is a business performance issue rather than a critical compliance or legal risk. Option B is incorrect because budget overruns represent an internal financial control issue. While concerning, it is far less severe than the legal and reputational threats posed by fraudulent claims. Option D is incorrect because losing the approval of industry peers or missing out on design awards is a minor creative concern and has no bearing on the company's legal liability or survival.